 EMERYVILLE, Calif.--BUSINESS WIRE-- earnings--Ligand Pharmaceuticals Incorporated NASDAQ: LGND will report second quarter 2022 financial results after the close of the U.S. financial markets on Monday, August 8, 2022 and will hold a conference call that same day beginning at 4:30 p.m. Eastern time. Speakers on the call will include Ligands CEO John Higgins, President and COO Matt Foehr, and Executive Vice President and CFO Matt Korenberg. Conference Call and Webcast Information What: Ligand conferenc 